Egypt’s Anti-depressants drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Clinical Depression is a mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life.
Egypt is a rapidly developing country with fast processes of urbanization. The health issues associated with young people are increasingly mirroring those in more developed countries, such as the prevalence of psychiatric disorders, especially depressive disorders. A nationwide survey conducted in 2018, showed the prevalence of anxiety and depression disorders, with approximately 43.7 percent of the respondents suffering from anxiety disorders and 30.1 percent suffering from depression, which is linked to substance abuse.
The rise in mental and behavioral disorders is estimated to be about 47% in Egypt from 2017 to 2030. This will sustain the market for anti-depressants in Egypt in the forecast period.
With rapid urbanization and change in lifestyle mirroring western trends, more and more people, especially the younger population, are increasingly susceptible to depression in Egypt. This is likely to increase the demand for anti-depressants in the Egyptian treatment market. Political instability in the middle east, lifestyle stressors, family issues are some of the common reasons due to which Egyptians are constantly subjected to mental strain.
Awareness for mental health illnesses is increasing and more people are actively seeking treatments. Therefore, new and innovative treatments and therapies will project a growing trend in the treatment market in the forecast period.